20830599

Source:http://linkedlifedata.com/resource/pubmed/id/20830599

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0017431, umls-concept:C0035525, umls-concept:C0087111, umls-concept:C0524910, umls-concept:C0681842, umls-concept:C0871261, umls-concept:C0936012, umls-concept:C0982327, umls-concept:C1328866, umls-concept:C1550147, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C2911692
pubmed:issue	3
pubmed:dateCreated	2011-3-31
pubmed:abstractText	This study aimed to develop a model for the pre-treatment prediction of sustained virological response (SVR) to peg-interferon plus ribavirin therapy in chronic hepatitis C.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9430794
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/Drug Carriers, http://linkedlifedata.com/resource/pubmed/chemical/Interferons, http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols, http://linkedlifedata.com/resource/pubmed/chemical/Ribavirin, http://linkedlifedata.com/resource/pubmed/chemical/alpha-Fetoproteins, http://linkedlifedata.com/resource/pubmed/chemical/gamma-Glutamyltransferase
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	1435-5922
pubmed:author	pubmed-author:HiramatsuNaokiN, pubmed-author:IwasakiManabuM, pubmed-author:IzumiNamikiN, pubmed-author:KurosakiMasayukiM, pubmed-author:SakamotoMinoruM, pubmed-author:SakamotoNaoyaN, pubmed-author:SugauchiFuminakaF, pubmed-author:SuzukiYoshiyukiY, pubmed-author:YatsuhashiHiroshiH
pubmed:issnType	Electronic
pubmed:volume	46
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	401-9
pubmed:meshHeading	pubmed-meshheading:20830599-Adolescent, pubmed-meshheading:20830599-Adult, pubmed-meshheading:20830599-Age Factors, pubmed-meshheading:20830599-Aged, pubmed-meshheading:20830599-Antiviral Agents, pubmed-meshheading:20830599-Data Mining, pubmed-meshheading:20830599-Decision Trees, pubmed-meshheading:20830599-Drug Carriers, pubmed-meshheading:20830599-Female, pubmed-meshheading:20830599-Genotype, pubmed-meshheading:20830599-Hepatitis C, Chronic, pubmed-meshheading:20830599-Humans, pubmed-meshheading:20830599-Interferons, pubmed-meshheading:20830599-Male, pubmed-meshheading:20830599-Middle Aged, pubmed-meshheading:20830599-Platelet Count, pubmed-meshheading:20830599-Polyethylene Glycols, pubmed-meshheading:20830599-Predictive Value of Tests, pubmed-meshheading:20830599-Retrospective Studies, pubmed-meshheading:20830599-Ribavirin, pubmed-meshheading:20830599-Sex Factors, pubmed-meshheading:20830599-Treatment Outcome, pubmed-meshheading:20830599-Young Adult, pubmed-meshheading:20830599-alpha-Fetoproteins, pubmed-meshheading:20830599-gamma-Glutamyltransferase
pubmed:year	2011
pubmed:articleTitle	Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis.
pubmed:affiliation	Division of Gastroenterology and Hepatology, Musashino Red Cross Hospital, 1-26-1 Kyonan-cho, Musashino, Tokyo 180-8610, Japan. kurosaki@musashino.jrc.or.jp
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study